Reviva Pharmaceuticals Holdings, Inc.

1.46 USD
+0.01 (+0.69%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Reviva Pharmaceuticals Holdings, Inc. stock is down -5.19% since 30 days ago. The next earnings date is Aug 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 5 June’s closed higher than May. 100% of analysts rate it a buy.

About Reviva Pharmaceuticals Holdings, Inc.

Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics. The company's lead product candidate is RP5063, which is in Phase III clinical trials for the treatment of schizophrenia. RP1208 that is in pre-clinical development studies for depression and obesity.

  • HC Wainwright & Co.
    Tue Jun 11, 06:14
  • Benchmark
    Tue May 28, 08:19